Extent Of DXM Abuse May Not Support Scheduling
This article was originally published in The Tan Sheet
Dextromethorphan abuse is increasing slightly, but the problem is not widespread, according to FDA. One expert notes the extent might not justify scheduling the cough suppressant as a controlled substance
You may also be interested in...
Dextromethorphan likely will escape scheduling as a controlled substance in the near term, but manufacturers and lawmakers should push efforts to curb abuse to keep the cough suppressant available OTC in the long run